Tomoki Inagaki

754 total citations
30 papers, 496 citations indexed

About

Tomoki Inagaki is a scholar working on Oncology, Epidemiology and Molecular Biology. According to data from OpenAlex, Tomoki Inagaki has authored 30 papers receiving a total of 496 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 14 papers in Epidemiology and 5 papers in Molecular Biology. Recurrent topics in Tomoki Inagaki's work include Viral-associated cancers and disorders (14 papers), Cytomegalovirus and herpesvirus research (12 papers) and Genetic Neurodegenerative Diseases (5 papers). Tomoki Inagaki is often cited by papers focused on Viral-associated cancers and disorders (14 papers), Cytomegalovirus and herpesvirus research (12 papers) and Genetic Neurodegenerative Diseases (5 papers). Tomoki Inagaki collaborates with scholars based in Japan, United States and Bangladesh. Tomoki Inagaki's co-authors include Hiroshi Kimura, Takayuki Murata, Yoshitaka Sato, Takahiro Watanabe, Atsuko Sugimoto, Shigehisa Mitake, Kenji Jinnai, Yoshihiro Fukuoka, Fumio Kanda and Hiroshi Kurisaki and has published in prestigious journals such as Hepatology, Neurology and Journal of Virology.

In The Last Decade

Tomoki Inagaki

28 papers receiving 485 citations

Peers

Tomoki Inagaki
Xi Luo China
Nicholas E. Martinez United States
Justin Lin United States
Adam Galle Australia
Tomoki Inagaki
Citations per year, relative to Tomoki Inagaki Tomoki Inagaki (= 1×) peers Eleonora Piras

Countries citing papers authored by Tomoki Inagaki

Since Specialization
Citations

This map shows the geographic impact of Tomoki Inagaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoki Inagaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoki Inagaki more than expected).

Fields of papers citing papers by Tomoki Inagaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomoki Inagaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoki Inagaki. The network helps show where Tomoki Inagaki may publish in the future.

Co-authorship network of co-authors of Tomoki Inagaki

This figure shows the co-authorship network connecting the top 25 collaborators of Tomoki Inagaki. A scholar is included among the top collaborators of Tomoki Inagaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomoki Inagaki. Tomoki Inagaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Inagaki, Tomoki, Somayeh Komaki, Suresh Nair, et al.. (2025). Design, development, and evaluation of gene therapeutics specific to KSHV-associated diseases. PubMed. 33(4). 201050–201050.
2.
Sagou, Ken, Yoshitaka Sato, Yusuke Okuno, et al.. (2024). Epstein-Barr virus lytic gene BNRF1 promotes B-cell lymphomagenesis via IFI27 upregulation. PLoS Pathogens. 20(2). e1011954–e1011954. 3 indexed citations
3.
Nakajima, K, et al.. (2024). Kaposi’s sarcoma-associated herpesvirus (KSHV) LANA prevents KSHV episomes from degradation. Journal of Virology. 98(2). e0126823–e0126823. 10 indexed citations
4.
Inagaki, Tomoki, Ashish Kumar, Somayeh Komaki, Kenichi Nakajima, & Yoshihiro Izumiya. (2024). An atlas of chromatin landscape in KSHV-infected cells during de novo infection and reactivation. Virology. 597. 110146–110146. 4 indexed citations
5.
Komaki, Somayeh, Tomoki Inagaki, Ashish Kumar, & Yoshihiro Izumiya. (2024). The Role of vIL-6 in KSHV-Mediated Immune Evasion and Tumorigenesis. Viruses. 16(12). 1900–1900. 3 indexed citations
6.
Miura, Hiroki, Tomoki Inagaki, Frank Y.S. Chuang, et al.. (2024). A LANA peptide inhibits tumor growth by inducing CHD4 protein cleavage and triggers cell death. Cell chemical biology. 31(11). 1909–1925.e7. 4 indexed citations
7.
Shimoda, Michiko, Tomoki Inagaki, Ryan R. Davis, et al.. (2023). Virally encoded interleukin-6 facilitates KSHV replication in monocytes and induction of dysfunctional macrophages. PLoS Pathogens. 19(10). e1011703–e1011703. 9 indexed citations
8.
Inagaki, Tomoki, Ashish Kumar, Chie Izumiya, et al.. (2023). KSHV vIL-6 enhances inflammatory responses by epigenetic reprogramming. PLoS Pathogens. 19(11). e1011771–e1011771. 7 indexed citations
9.
Sato, Yoshitaka, Yusuke Okuno, Ken Sagou, et al.. (2022). Epstein–Barr virus tegument protein BGLF2 in exosomes released from virus-producing cells facilitates de novo infection. Cell Communication and Signaling. 20(1). 95–95. 12 indexed citations
10.
Inagaki, Tomoki, Yoshitaka Sato, Jumpei Ito, et al.. (2021). Direct Evidence of Abortive Lytic Infection-Mediated Establishment of Epstein-Barr Virus Latency During B-Cell Infection. Frontiers in Microbiology. 11. 575255–575255. 25 indexed citations
11.
Sato, Yoshitaka, Takahiro Watanabe, C. Suzuki, et al.. (2019). S-Like-Phase Cyclin-Dependent Kinases Stabilize the Epstein-Barr Virus BDLF4 Protein To Temporally Control Late Gene Transcription. Journal of Virology. 93(8). 20 indexed citations
12.
Hasegawa, Yoshihiro, Toshiyuki Yamamoto, Tomoki Inagaki, & Kazuhiro Suzuki. (2000). A Swallowing Study, Based on Clinico-Pathological Evaluation, Performed by Video-fluoroscopy.. Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics. 37(1). 63–67. 2 indexed citations
13.
Inagaki, Tomoki, et al.. (2000). Bibliographical Study of the Concurrent Existence of Anticentromere and Antitopoisomerase I Antibodies. Clinical Rheumatology. 19(6). 435–441. 8 indexed citations
14.
Hashizume, Yoshio, et al.. (1996). Autopsy Findings of Atheromatous Embolism to the Spinal Cord.. Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics. 33(12). 935–939. 1 indexed citations
15.
Ono, S., Fumio Kanda, Keiichi Takahashi, et al.. (1996). Neuronal loss in the medullary reticular formation in myotonic dystrophy. Neurology. 46(1). 228–231. 33 indexed citations
16.
Inagaki, Tomoki, et al.. (1996). Autopsy Findings of Pontine Lesions in the Elderly.. Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics. 33(7). 524–531. 1 indexed citations
17.
Yamada, Tamaki, Makoto Hoshino, Tomihiro Hayakawa, et al.. (1996). Bile secretion in rats with indomethacin-induced intestinal inflammation. American Journal of Physiology-Gastrointestinal and Liver Physiology. 270(5). G804–G812. 17 indexed citations
18.
Ono, S., Fumio Kanda, Keiichi Takahashi, et al.. (1995). Neuronal cell loss in the dorsal raphe nucleus and the superior central nucleus in myotonic dystrophy: a clinicopathological correlation. Acta Neuropathologica. 89(2). 122–125. 11 indexed citations
19.
Inagaki, Tomoki, T. Yamamoto, Takashi Niimi, et al.. (1995). A 115-Year-Old Woman: The Oldest Individual in Japan.. Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics. 32(3). 172–177. 1 indexed citations
20.
Inagaki, Tomoki, Takatsugu Yamamoto, Kazuya Nokura, et al.. (1992). Five Year Follow-up Study on Dementia in Institutions for the Elderly.. Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics. 29(10). 729–734. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026